1.Surgical treatment for diabetic vitreoretinal diseases: a review.

Sharma T, Fong A, Lai TY, Lee V, Das S, Lam D.

Clin Exp Ophthalmol. 2016 May;44(4):340-54. doi: 10.1111/ceo.12752. Epub 2016 May 11.

PMID: 27027299 Review.

2.Intravitreal Injection–Technique and Safety.

Lai TY, Liu S, Das S, Lam DS.

Asia Pac J Ophthalmol (Phila). 2015 Nov-Dec;4(6):321-8. doi: 10.1097/APO.0000000000000146.

PMID: 26649760

3.Penetrating ocular trauma by nail of a badminton feather shuttle cock: A rare case report.

Das S, Singh V, Saurabh K.

Indian J Ophthalmol. 2020 Jun;68(6):1209-1211. doi: 10.4103/ijo.IJO_1681_19.

PMID: 32461485 Free PMC article.

4.The Latest Updates and Management of Endophthalmitis.

Das S, Bhende PS, Lam DS.

Asia Pac J Ophthalmol (Phila). 2016 May;5(3):167-70. doi: 10.1097/APO.0000000000000208.

PMID: 27183288 No abstract available.

5.The Rate of Endophthalmitis After Intravitreal Injections.

Das S, Lai T, Liu S, Lam D.

Asia Pac J Ophthalmol (Phila). 2016 Mar-Apr;5(2):165-6. doi: 10.1097/APO.0000000000000196.

PMID: 26939114 No abstract available.

6.Bilateral sub-internal limiting membrane haemorrhage in acute myeloid leukaemia.

Goel S, Das D, Saurabh K, Roy R, Das S, Nigam E.

Clin Exp Optom. 2021 Jan;104(1):122-123. doi: 10.1111/cxo.13106.

PMID: 32495407 No abstract available.

7.Postoperative necrotizing scleritis: a report of four cases.

Das S, Saurabh K, Biswas J.

Middle East Afr J Ophthalmol. 2014 Oct-Dec;21(4):350-3. doi: 10.4103/0974-9233.142277.

PMID: 25371644 Free PMC article.

8.Endophthalmitis caused by Alcaligenes faecalis: a case series.

Pal SS, Panigrahi PK, Roy R, Nandi K, Das S.

Ocul Immunol Inflamm. 2013 Dec;21(6):446-8. doi: 10.3109/09273948.2013.817592. Epub 2013 Jul 29.

PMID: 23895234

9.Risk Factors for Endophthalmitis after Pars Plana Vitrectomies in a Tertiary Eye Institute in India.

Bhende M, Raman R, Singh N, Jain M, Sharma T, Gopal L, Bhende PS, Srinivasan S, Jambulingam M; Sankara Nethralaya Vitreoretinal Study Group.

Ophthalmol Retina. 2018 Aug;2(8):779-784. doi: 10.1016/j.oret.2018.01.001. Epub 2018 Feb 17.

PMID: 31047529

10.Quantitative Reduction in Central Foveal Thickness After First Anti-VEGF Injection as a Predictor of Final Outcome in BRVO Patients.

Roy R, Saurabh K, Ghose A, Chandrasekharan DP, Sharma P, Pal SS, Das S.

Asia Pac J Ophthalmol (Phila). 2017 May-Jun;6(3):261-265. doi: 10.22608/APO.201644. Epub 2017 Mar 29.

PMID: 28379652

11.Variation in Visual Outcome to Anti-Vascular Endothelial Growth Factors in Choroidal Neovascular Membrane Developing in Eyes with Previously Untreated Versus Focal Laser-Treated Central Serous Chorioretinopathy.

Roy R, Saurabh K, Das D, Panigrahi PK, Das S, Pal SS, Jain A.

Semin Ophthalmol. 2017;32(6):781-786. doi: 10.1080/08820538.2016.1182556. Epub 2016 Aug 17.

PMID: 27533737